These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26775546)

  • 41. [Indications for ACE inhibitors in chronic heart failure].
    Erdmann E
    Z Kardiol; 1994; 83 Suppl 4():75-9. PubMed ID: 7856285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry.
    Bart BA; Ertl G; Held P; Kuch J; Maggioni AP; McMurray J; Michelson EL; Rouleau JL; Warner Stevenson L; Swedberg K; Young JB; Yusuf S; Sellers MA; Granger CB; Califf RM; Pfeffer MA
    Eur Heart J; 1999 Aug; 20(16):1182-90. PubMed ID: 10448027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical course and outcome of children with single ventricle physiology at King Chulalongkorn Memorial Hospital.
    Khongphatthanayothin A; Rattanawilaisak K; Benjacholamas V; Numchaisiri C; Sirichonkolthong B; Chotivitayatarakorn P; Lertsapcharoen P
    J Med Assoc Thai; 2006 Sep; 89(9):1420-6. PubMed ID: 17100379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. No consensus on withholding angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before spinal anaesthesia.
    Bøgebjerg MK
    Dan Med J; 2012 Dec; 59(12):A4543. PubMed ID: 23290284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme inhibitors in hypertension or congestive heart failure?
    Nawarskas JJ; Spinler SA
    Pharmacotherapy; 1998; 18(5):1041-52. PubMed ID: 9758314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are all angiotensin-converting enzyme inhibitors interchangeable?
    Furberg CD; Pitt B
    J Am Coll Cardiol; 2001 Apr; 37(5):1456-60. PubMed ID: 11300461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cardioprotection and nephroprotection with ACE-inhibitors. Workshop, Bonn, 1-2 February 1990].
    Klin Wochenschr; 1991; 69 Suppl 24():1-74. PubMed ID: 1678023
    [No Abstract]   [Full Text] [Related]  

  • 48. Who needs nine ACE inhibitors?
    Drug Ther Bull; 1995 Jan; 33(1):1-3. PubMed ID: 7587979
    [No Abstract]   [Full Text] [Related]  

  • 49. Fetal risk from ACE inhibitors in the first trimester.
    Mitchell AA
    BMJ; 2011 Oct; 343():d6667. PubMed ID: 22010131
    [No Abstract]   [Full Text] [Related]  

  • 50. Transplant in Single Ventricle Physiology: The Fourth Stage?
    Hsu DT; Lui GK
    J Am Coll Cardiol; 2023 Sep; 82(12):1242-1244. PubMed ID: 37704314
    [No Abstract]   [Full Text] [Related]  

  • 51. ACE inhibitors and the risk of lung cancer-is there causality?
    Strauss MH; Sipahi I; Hall AS
    Br J Cancer; 2023 Sep; 129(4):570-571. PubMed ID: 37400679
    [No Abstract]   [Full Text] [Related]  

  • 52. ACE inhibitors impair neutrophil bacterial killing.
    Wang M
    Nat Rev Nephrol; 2021 Oct; 17(10):633. PubMed ID: 34385675
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of ACE inhibitors in Fontan: Rational or irrational?
    Wilson TG; Iyengar AJ; Winlaw DS; Weintraub RG; Wheaton GR; Gentles TL; Ayer J; Grigg LE; Justo RN; Radford DJ; Bullock A; Celermajer DS; Dalziel K; Schilling C; d'Udekem Y;
    Int J Cardiol; 2016 May; 210():95-9. PubMed ID: 26938683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of Enalapril in Infants: Data from the Pediatric Heart Network Infant Single Ventricle Trial.
    Mathur K; Hsu DT; Lamour JM; Aydin SI
    J Pediatr; 2020 Dec; 227():218-223. PubMed ID: 32768465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiotensin-Converting Enzyme Inhibitor Prescription for Patients With Single Ventricle Physiology Enrolled in the NPC-QIC Registry.
    Hansen JE; Brown DW; Hanke SP; Bates KE; Tweddell JS; Hill G; Anderson JB
    J Am Heart Assoc; 2020 May; 9(10):e014823. PubMed ID: 32384002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel Therapeutic Strategies in Heart Failure in Adult Congenital Heart Disease: of Medicines and Devices.
    Vaikunth S; Sundaravel S; Saef J; Ortega-Legaspi J
    Curr Heart Fail Rep; 2023 Oct; 20(5):401-416. PubMed ID: 37582901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heart failure in single right ventricle congenital heart disease: physiological and molecular considerations.
    Garcia AM; Beatty JT; Nakano SJ
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H947-H965. PubMed ID: 32108525
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment.
    Pandya NR; Alphonso N; Tu Q; Venugopal P; Schlapbach LJ
    Front Cardiovasc Med; 2018; 5():121. PubMed ID: 30234130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiotensin converting enzyme inhibitors and interstage failure in infants with hypoplastic left heart syndrome.
    Yimgang DP; Sorkin JD; Evans CF; Abraham DS; Rosenthal GL
    Congenit Heart Dis; 2018 Jul; 13(4):533-540. PubMed ID: 30019493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. State of the art of the Fontan strategy for treatment of univentricular heart disease.
    van der Ven JPG; van den Bosch E; Bogers AJCC; Helbing WA
    F1000Res; 2018; 7():. PubMed ID: 30002816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.